You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

interleukin-1 receptor-associated kinase 1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Singapore (Pacritinib)

Recruiting
  • Breast Cancer
  • Singapore, Singapore
    National University Hospital
Aug 17, 2020

Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Biopsy
  • +8 more
  • (no location specified)
Jan 13, 2023

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Beta Endorphins,Interleukin 1 and Interleukin 38 in Covid

Recruiting
  • Covid Patients
  • βeta endorphins, interleukin 6 and interleukin 38
  • Assiut, Egypt
    Assiut university
Jan 22, 2022

Chronic Kidney Diseases Trial in Durham (Baricitinib, Placebo)

Recruiting
  • Chronic Kidney Diseases
  • Durham, North Carolina
    Duke Research at Pickett Road
Dec 15, 2022

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

Not yet recruiting
  • Pericarditis
  • IL1RA Antibody Assay
  • suPAR Testing
  • Homburg, Germany
  • +8 more
Jun 22, 2023

Netosis During COVID-19, Under Treatment With

Active, not recruiting
  • Covid19
    • Paris, France
    • +1 more
    Mar 30, 2022

    Vitamin D Receptor, Interleukin-1A and Interleukin-1B Gene

    Completed
    • Periodontitis
    • Polymorphism, Restriction Fragment Length
      • İstanbul, Maltepe, Turkey
      • +1 more
      Nov 30, 2021

      Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy

      Not yet recruiting
      • Sepsis-Associated Encephalopathy
        • Yinchuan, Ningxia, China
          Department of Anesthesiology, General Hospital of Ningxia Medica
        Jul 8, 2022

        Interleukin-4 Receptor, Monoclonal Antibody Trial (Interleukin-4 receptor responders 1, Interleukin-4 receptor responders 2,

        Not yet recruiting
        • Interleukin-4 Receptor
        • Monoclonal Antibody
        • Interleukin-4 receptor responders 1
        • +2 more
        • (no location specified)
        Jul 20, 2022

        Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)

        Terminated
        Has Results
        • Rhabdomyosarcoma
        • +2 more
        • Los Angeles, California
        • +1 more
        Mar 17, 2022

        Pre-frail Elderly Trial in Jakarta (Cholecalciferol, Placebo)

        Completed
        • Pre-frail Elderly
        • Jakarta, DKI Jakarta, Indonesia
          Cipto Mangunkusumo General Hospital
        Jan 25, 2023

        Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

        Completed
        • Intracerebral Haemorrhage
        • IL-1Ra Kineret®
        • IL-1Ra Placebo
        • Manchester, North West, United Kingdom
          Salford Royal NHS Foundation Trust
        Oct 4, 2021

        MuSK Myasthenia Gravis Trial (MuSK-CAART)

        Not yet recruiting
        • MuSK Myasthenia Gravis
        • MuSK-CAART
        • (no location specified)
        Jul 5, 2022

        Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

        Active, not recruiting
        • Estrogen Receptor-positive Breast Cancer
        • +5 more
        • PI3K inhibitor BYL719
        • +3 more
        • Boston, Massachusetts
        • +1 more
        Oct 14, 2022

        ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)

        Recruiting
        • ANCA Associated Vasculitis
        • +2 more
        • Edinburgh, United Kingdom
          Centre for Cardiovascular Science, Queen's Medical Research Inst
        Jan 26, 2023

        Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

        Not yet recruiting
        • Acneiform Eruption Due to Chemical
        • +2 more
        • HT-001 2% Topical Gel
        • +3 more
        • (no location specified)
        Dec 3, 2022

        Advanced/Metastatic Solid Tumors Trial in Frankston, Nedlands, Beijing (EMB07)

        Not yet recruiting
        • Advanced/Metastatic Solid Tumors
        • Frankston, Victoria, Australia
        • +2 more
        Nov 3, 2022

        NSCLC Trial in Seoul (BBT-176, Cetuximab)

        Recruiting
        • NSCLC
        • Seongnam-si, Gyeonggi-do, Korea, Republic of
        • +3 more
        Jan 6, 2023

        Personalised Disease Monitoring in Metastatic Breast Cancer

        Recruiting
        • Breast Cancer Metastatic
        • Estrogen Receptor-positive Breast Cancer
          • Gothenburg, Sweden
          • +6 more
          Dec 7, 2022

          COVID-19 Trial in Halifax (Baricitinib (janus kinase inhibitor), Remdesivir (antiviral) + barictinib (janus kinase inhibitor),

          Recruiting
          • COVID-19
          • Baricitinib (janus kinase inhibitor)
          • +3 more
          • Halifax, Nova Scotia, Canada
            Nova Scotia Health Authority
          Mar 9, 2022

          T-cell Lymphoma Trial in Worldwide (CPI-818)

          Recruiting
          • T-cell Lymphoma
          • Palo Alto, California
          • +21 more
          Jun 20, 2022

          Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

          Recruiting
          • Colorectal Cancer
          • +11 more
          • Cleveland, Ohio
            University Hospitals Cleveland Medical Center, Case Comprehensiv
          Jan 18, 2023

          Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

          Completed
          • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • +4 more
          • Eltrombopag Olamine
          • Houston, Texas
            M D Anderson Cancer Center
          Jan 4, 2022

          Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

          Recruiting
          • Sarcoma, Synovial
          • +8 more
          • CYCLOPHOSPHAMIDE and FLUDARABIN
          • +3 more
          • Jerusalem, Israel
            Hadassah Medical Organization
          Mar 15, 2022